Education
About Us
Working with TipRanks
Follow Us
Definium Therapeutics (DFTX)
NASDAQ:DFTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -527.00K | $ -3.16M | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -103.92M | $ -93.87M | $ -66.33M | $ -93.85M | $ -33.03M |
| EBITDA | $ -105.87M | $ -92.57M | $ -63.15M | $ -91.24M | $ -33.57M |
| Net Income | $ -108.68M | $ -95.73M | $ -56.80M | $ -93.04M | $ -34.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 273.74M | $ 99.70M | $ 142.14M | $ 133.54M | $ 80.09M |
| Total Assets | $ 302.15M | $ 124.54M | $ 169.99M | $ 164.00M | $ 81.52M |
| Total Debt | $ 21.85M | $ 14.13M | $ 72.00K | $ 0.00 | $ 0.00 |
| Net Debt | $ -251.89M | $ -85.58M | $ -142.07M | $ -133.54M | $ -80.09M |
| Total Liabilities | $ 60.70M | $ 46.41M | $ 19.08M | $ 12.34M | $ 5.65M |
| Stockholders' Equity | $ 241.45M | $ 78.13M | $ 150.92M | $ 151.66M | $ 75.87M |
| Cash Flow | |||||
| Free Cash Flow | $ -79.13M | $ -64.36M | $ -50.14M | $ -45.82M | $ -23.60M |
| Operating Cash Flow | $ -79.13M | $ -64.36M | $ -50.14M | $ -45.82M | $ -23.60M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ -297.00K | $ 0.00 |
| Financing Cash Flow | $ 253.20M | $ 21.85M | $ 59.05M | $ 98.82M | $ 96.70M |
Definium Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.